Helius Medical Technologies Inc (OTCMKTS:HSDT) insider Philippe Deschamps bought 127,551 shares of Helius Medical Technologies stock in a transaction dated Friday, December 22nd. The stock was acquired at an average cost of $1.96 per share, with a total value of $249,999.96. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Helius Medical Technologies Inc (HSDT) opened at $2.25 on Friday. Helius Medical Technologies Inc has a 52 week low of $1.29 and a 52 week high of $4.14.
Separately, ValuEngine downgraded Helius Medical Technologies from a “hold” rating to a “sell” rating in a research note on Friday, December 1st.
COPYRIGHT VIOLATION NOTICE: This article was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://ledgergazette.com/2018/01/13/helius-medical-technologies-inc-hsdt-insider-philippe-deschamps-buys-127551-shares.html.
About Helius Medical Technologies
Helius Medical Technologies, Inc is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device.
Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.